An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area
Completed · Not applicable · NCT05538728
Conditions: Wrinkles in Decolletage
At a glance
- Research payments reported, 2025
- $1,800
- U.S. investigators named
- 2
- Sites paid
- 2
- Planned or actual enrollment
- 30
About the trial
- Sponsor
- Galderma R&D
- Tested
- poly-l-lactic acid (Sculptra) (device)
- Dates
- Started 2022-08-31; completion 2023-08-08
- Results posted
- Yes
This is a prospective open-label study to evaluate safety and effectiveness of two different reconstitution volumes of poly-l-lactic acid (PLLA) for correction of wrinkles in the décolletage area.
From ClinicalTrials.gov, last updated 2024-08-20. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Galderma Laboratories, L.P. reported $1,800 in research payments for this study in 2025 (2 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Amir Moradi, MD ENT (Otolaryngology) · Vista, CA
- Jeffrey L. Sugarman, M.D., PH.D. Dermatology · Santa Rosa, CA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Pacific Clinical Innovations Inc $1,000
- Jeffrey Sugarman $800
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.